ZENAGAMTIDE
UNII T2EA5S9XJ5

Substance Identification & Data

This profile provides standardized clinical and technical data for Zenagamtide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T2EA5S9XJ5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3005889-81-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T2EA5S9XJ5

CAS Registry Number

3005889-81-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZENAGAMTIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C224807

National Cancer Institute reference terminology for clinical and research data.

INN ID

13389

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zenagamtide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZENAGAMTIDE

Common Names & Synonyms

7-37-GLUCAGON-LIKE PEPTIDE 1 (8-(2-METHYLALANINE),22-GLUTAMIC ACID,26-ARGININE,34-ARGININE,37-(N6-(N-(17-CARBOXY-1-OXOHEPTADECYL)-L-.GAMMA.-GLUTAMYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL-2-(2-(2-AMINOETHOXY)ETHOXY)ACETYL)-L-LYSINE)) (HUMAN) FUSION PEPTIDE LINKER (GGGG) FUSION PROTEIN WITH AMYLIN RECEPTOR AGONIST (SYNTHETIC 33-AMINO ACID)

GLUCAGON-LIKE PEPTIDE 1(7-37) (HUMAN GLP-1(7-37)) (1-31), (A8>2-MEALA2, G22>E16, K26>R20, K34>R28, G37>K31)-VARIANT, FUSED VIA A G4 PEPTIDE LINKER (32-35) TO AN ARTIFICIAL 33-PEPTIDE (36-68, AMYLIN RECEPTOR AGONIST), 68-AMIDE, SUBSTITUTED AT N6 OF THE LYSINE RESIDUE 31 WITH A (22S)-22,40-DICARBOXY-10,19,24-TRIOXO-3,6,12,15-TETRAOXA-9,18,23-TRIAZATETRACONTAN-1-OYL GROUP

ZENAGAMTIDE [INN]

External Clinical & Regulatory Resources

Previous UNIIT2E45FB2KU

Next UNIIT2EIE22I4V